US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Oxford Immunotec Global PLC (OXFD)
Oxford Immunotec Global PLC (OXFD) Noticias

OXFD

Oxford Immunotec Global (OXFD)

Oxford Immunotec Global PLC

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OXFD

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/02/2022	14:27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OXFD	Oxford Immunotec Global PLC
12/03/2021	15:38	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OXFD	Oxford Immunotec Global PLC
12/03/2021	15:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OXFD	Oxford Immunotec Global PLC
08/03/2021	16:06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:OXFD	Oxford Immunotec Global PLC
08/03/2021	08:24	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:OXFD	Oxford Immunotec Global PLC
04/03/2021	13:43	PR Newswire (US)	Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection...	NASDAQ:OXFD	Oxford Immunotec Global PLC
02/03/2021	16:01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:OXFD	Oxford Immunotec Global PLC
26/02/2021	16:37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OXFD	Oxford Immunotec Global PLC
08/02/2021	08:15	GlobeNewswire Inc.	Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to...	NASDAQ:OXFD	Oxford Immunotec Global PLC
04/02/2021	08:15	GlobeNewswire Inc.	Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemi...	NASDAQ:OXFD	Oxford Immunotec Global PLC
29/01/2021	08:58	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:OXFD	Oxford Immunotec Global PLC
29/01/2021	08:28	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:OXFD	Oxford Immunotec Global PLC
14/01/2021	08:15	GlobeNewswire Inc.	New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19	NASDAQ:OXFD	Oxford Immunotec Global PLC
13/01/2021	08:15	GlobeNewswire Inc.	Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vacci...	NASDAQ:OXFD	Oxford Immunotec Global PLC
07/01/2021	06:18	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:OXFD	Oxford Immunotec Global PLC
07/01/2021	06:00	Business Wire	PerkinElmer to Acquire Oxford Immunotec Global PLC	NASDAQ:OXFD	Oxford Immunotec Global PLC
31/12/2020	09:23	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:OXFD	Oxford Immunotec Global PLC
16/12/2020	08:15	GlobeNewswire Inc.	Oxford Immunotec Announces the Foundation of the Global T Cell Expert Consortium, Whose First Meeting Took Place This Week	NASDAQ:OXFD	Oxford Immunotec Global PLC
10/12/2020	08:15	GlobeNewswire Inc.	Oxford Immunotec Announces the Approval of the T-Cell Select™ Reagent Kit, Used to Automate the T-SPOT®.TB Test Workflow, ...	NASDAQ:OXFD	Oxford Immunotec Global PLC
02/12/2020	08:00	GlobeNewswire Inc.	Oxford Immunotec Signs Exclusive Distributor Agreement with RIKEN Genesis, a Subsidiary of Sysmex, to Market the T-SPOT® Dis...	NASDAQ:OXFD	Oxford Immunotec Global PLC
23/11/2020	06:30	GlobeNewswire Inc.	Oxford Immunotec to Hold a Virtual Investor Event on December 17, 2020	NASDAQ:OXFD	Oxford Immunotec Global PLC
10/11/2020	08:00	GlobeNewswire Inc.	Data Showing SARS-CoV-2 Reactive T Cells are Associated with Protection from COVID-19 – and Can Be Both Detected and Measur...	NASDAQ:OXFD	Oxford Immunotec Global PLC
05/11/2020	08:00	GlobeNewswire Inc.	Oxford Immunotec Files Submission to Food and Drug Administration (FDA) for the T-Cell Select™ Reagent Kit	NASDAQ:OXFD	Oxford Immunotec Global PLC
03/11/2020	09:02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OXFD	Oxford Immunotec Global PLC
03/11/2020	06:00	GlobeNewswire Inc.	Oxford Immunotec Reports Third Quarter 2020 Financial Results	NASDAQ:OXFD	Oxford Immunotec Global PLC
22/10/2020	04:30	GlobeNewswire Inc.	UK Vaccines Taskforce has Selected Oxford Immunotec as the Sole Supplier of T cell Testing for SARS-CoV-2 Specific Responses ...	NASDAQ:OXFD	Oxford Immunotec Global PLC
21/10/2020	15:05	GlobeNewswire Inc.	Oxford Immunotec Schedules Third Quarter 2020 Earnings Release and Conference Call for November 3, 2020	NASDAQ:OXFD	Oxford Immunotec Global PLC
29/09/2020	08:00	GlobeNewswire Inc.	Oxford Immunotec Announces Food and Drug Administration (FDA) Clearance of the T-SPOT®.TB Test for Use in Pediatrics Over th...	NASDAQ:OXFD	Oxford Immunotec Global PLC
22/09/2020	08:00	GlobeNewswire Inc.	Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS...	NASDAQ:OXFD	Oxford Immunotec Global PLC
02/09/2020	15:08	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:OXFD	Oxford Immunotec Global PLC

Showing the most relevant articles for your search:NASDAQ:OXFD

1 2 3 4 5 6 Próxima >

Deutsche Telekom (QX)

Financial Select Sector

Gold vs US Dollar

Invesco QQQ Trust Series 1

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones